BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: NADPH oxidase 2 (NOX2)

September 29, 2016 7:00 AM UTC

Mouse studies suggest inhibiting NOX2 could help treat post-influenza pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA). In mice co-infected with influenza virus and MRSA and rece...